High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction.
about
CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptideInhibition of T cell response to native low-density lipoprotein reduces atherosclerosisCirculating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women.Modulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)/J miceVaccination to modulate atherosclerosisLymphocyte migration into atherosclerotic plaque.Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for interventionDetection of circulating IgG antibodies to apolipoprotein B100 in acute myocardial infarction.Beyond vascular inflammation--recent advances in understanding atherosclerosis.Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis.2015 Russell Ross Memorial Lecture in Vascular Biology: Protective Autoimmunity in AtherosclerosisAssociations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetesHuman IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60-Year-Olds.T-Cells Specific for a Self-Peptide of ApoB-100 Exacerbate Aortic Atheroma in Murine Atherosclerosis.Progress and future opportunities in the development of vaccines against atherosclerosis.The utility of collaborative biobanks for cardiovascular research.Vaccines against atherosclerosis.Obesity modulates the immune response to oxidized LDL in hypertensive patients.Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges.Chlamydomonas reinhardtii chloroplasts express an orally immunogenic protein targeting the p210 epitope implicated in atherosclerosis immunotherapies.Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells.Autoantibodies against aldehyde-modified collagen type IV are associated with risk of development of myocardial infarction.Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
P2860
Q28732168-1AB071FE-A295-4B5C-8C68-FA75254C39F2Q33839918-F024D32D-6150-4206-A2CF-11FF7D23BA97Q35175305-65234E63-17F7-438A-9BD2-F96D0D716654Q35591762-04A56C42-ACC3-4DD3-96AC-876E266F1687Q35600876-EE7E6278-9F27-46EA-81AC-221627AA6707Q35600904-68DEF9AD-3A63-4B44-96F9-2B1E03D2098EQ35998510-EBAFF0F9-6966-46BC-BA05-A11AA14C3B5FQ36042620-B2D60CE6-3110-4CAA-9903-53F293B9234CQ36079808-7577D8BC-D569-44C2-BEC9-4156F31361D1Q36279562-07E783BB-EFA6-4F2D-BA18-9EA7788DC028Q37146276-01B8E31F-129D-4750-BCE1-F930CE0517A4Q37207913-0B09DF04-2CB1-4C1A-B68D-F9A439ECE782Q37556461-9EA85B26-5561-454B-AFEA-8624C78078B4Q37660865-30FFB043-8CA4-4803-9C9E-F550436B192CQ37835406-353F4497-3AB9-4049-AEFA-0C3C4CB77D7FQ37928825-C7F4435B-D3F2-4800-9353-79D7FEA0D3C8Q38089941-015DB635-1D2C-4240-8E41-9F8E6C741021Q38316537-66324BCA-BED0-4D6A-8FC5-EA39BEE51EEBQ38346930-CE41A61B-E9CE-4853-B288-6CCBD41F0571Q39990498-7F6EEA14-CB53-4151-A90D-1CE67703DCD6Q46473311-0A6AA19B-4A38-4854-9848-573452DC92D6Q47750132-942BAC17-B54C-4A0E-8135-F98607482DD3Q49072554-EEDEE32F-A8B5-40D0-8928-CBD737B605C8
P2860
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
High plasma concentrations of ...... risk of myocardial infarction.
@en
High plasma concentrations of ...... risk of myocardial infarction.
@nl
type
label
High plasma concentrations of ...... risk of myocardial infarction.
@en
High plasma concentrations of ...... risk of myocardial infarction.
@nl
prefLabel
High plasma concentrations of ...... risk of myocardial infarction.
@en
High plasma concentrations of ...... risk of myocardial infarction.
@nl
P2093
P2860
P921
P356
P1476
High plasma concentrations of ...... risk of myocardial infarction.
@en
P2093
Ann Samnegard
Carl-Göran Ericsson
Gunilla N Fredrikson
Jan Nilsson
John Ohrvik
Per Sjögren
Rachel M Fisher
P2860
P304
P356
10.1093/EURHEARTJ/EHN336
P577
2008-07-29T00:00:00Z